Clinical Trials Logo

Migraine clinical trials

View clinical trials related to Migraine.

Filter by:

NCT ID: NCT00617695 Completed - Migraine Clinical Trials

Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of Zolmitriptan (Zomig) nasal spray, 5.0 mg, compared with placebo (inactive drug) for 2 migraine headaches over a 3-month period in adolescent patients (aged 12 to 17 years) with migraine headaches

NCT ID: NCT00610727 Completed - Migraine Clinical Trials

Staccato Prochlorperazine Single Dose PK Study

Start date: August 2004
Phase: Phase 1
Study type: Interventional

The objective of this study was to evaluate the tolerability, safety, and pharmacokinetics of inhaled prochlorperazine

NCT ID: NCT00599586 Completed - Migraine Clinical Trials

Randomized Controlled Trial of Treating Migraine With Acupuncture

Start date: November 2007
Phase: N/A
Study type: Interventional

The purpose of the study is to testify whether acupuncture is effective for migraine, and provide evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."

NCT ID: NCT00567086 Completed - Migraine Clinical Trials

Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine

Start date: October 2006
Phase: Phase 2
Study type: Interventional

To evaluate the effects of a single sc administration of TEZAMPANEL at one of three different dosage levels compared to placebo, employing traditional measures of efficacy and safety in the treatment of a single episode of acute migraine.

NCT ID: NCT00562289 Completed - Ischemic Stroke Clinical Trials

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence

CLOSE
Start date: December 2007
Phase: Phase 3
Study type: Interventional

A patent foramen ovale (PFO) is found more frequently in patients with an ischemic stroke than in control subjects. Therapeutic options to prevent stroke recurrence include antiplatelet drugs, oral anticoagulants, and transcatheter closure of the foramen. However, there are no published studies showing convincingly the superiority of any one of these strategies in preventing stroke recurrence. The aim of this randomized clinical trial is to assess whether chronic anticoagulation on the one hand and transcatheter on the other hand are superior to chronic antiplatelet therapy in preventing stroke recurrence.

NCT ID: NCT00551980 Completed - Migraine Clinical Trials

The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community

Start date: October 2007
Phase: Phase 3
Study type: Interventional

This study is a controlled, cluster randomised, interventional trial to evaluate the effectiveness of a workplace cognitive and physical program (Intervention), in reducing the frequency of head and neck pain in an extensive working population.

NCT ID: NCT00521196 Completed - Migraine Clinical Trials

Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)

Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a painless and noninvasive procedure called Transcranial Direct Current Stimulation (tDCS) can be an effective therapy for the treatment of migraine and migraine-associated pain. Stimulation of the motor cortex with tDCS has already been shown to relieve pain in patients with other chronic pain syndromes, including traumatic spinal cord injury and fibromyalgia. Patients with migraine are usually extremely sensitive to pain. A treatment that targets the areas of the brain that are related to the experience of pain may also help decrease pain in patients with migraine. Pain control with this localized approach may help avoid the problems due to pain medications that affect all organs in the body. We hypothesize that 10 sessions of Transcranial Direct Current Stimulation (tDCS) applied over the area of the brain that controls pain and motor function will decrease pain and headache frequency in patients with migraine.

NCT ID: NCT00516737 Completed - Migraine Clinical Trials

Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)

Start date: October 3, 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.

NCT ID: NCT00510419 Completed - Migraine Clinical Trials

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Start date: July 2007
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to evaluate an investigational auto-injector system for delivering sumatriptan under the skin for a single migraine attack. The study could take approximately 5 weeks and will include about 3 office visits to the study doctor, the patient will be contacted every 2 weeks until the patient experiences a migraine and uses the auto-injector. The last visit will be done by a telephone follow-up call.

NCT ID: NCT00489476 Completed - Migraine Clinical Trials

Staccato® Loxapine for Inhalation in Patients With Migraine Headache

Start date: June 2007
Phase: Phase 2
Study type: Interventional

The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.